Streetbeat News

Products Services

GSK

GSK's Phase 3 trial of Arexvy, an RSV vaccine, co-administered with Shingrix, a shingles vaccine, met its primary endpoint in adults 50 and older. The vaccines were well tolerated, showing acceptable safety profiles, advancing the science of co-administration of adult vaccines.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 11:04 am

VVOS

Vivos Therapeutics has received FDA 510(k) clearance for its DNA appliance to treat moderate to severe pediatric sleep apnea and snoring in children aged 6 to 17. This approval could enhance Vivos' market position in pediatric sleep disorder treatments.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 11:02 am

GXO

GXO Logistics has entered into a new agreement with Reflex Robotics to pilot Reflex's robotics solution in live operations. This partnership aims to enhance GXO's operational efficiency through advanced robotics technology.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 11:01 am

BMY

Bristol Myers Squibb announced that new data from the Phase 3 DAYBREAK trial showed sustained decreased rates of brain volume loss in patients with relapsing forms of multiple sclerosis treated with Zeposia (Ozanimod) during the open-label extension.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 11:00 am

ACM

AECOM has been selected by the San Diego County Regional Airport Authority to provide program management services for projects at San Diego International Airport, including the $3.8 billion New Terminal 1 program and the modernization of Terminal 2 East.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 10:57 am

BDX

Becton, Dickinson and Company (BD) announced the commercial release of the BD Neopak Xtraflow Glass Prefillable Syringe and an expansion of the BD Neopak Glass Prefillable Syringe platform.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 10:51 am

MRK

The FDA has approved Merck's Keytruda in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with unresectable advanced or metastatic malignant pleural mesothelioma.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 10:47 am

KGEI

Kolibri Global Energy has completed drilling its first three 1.5 mile lateral wells in the Tishomingo Field, Oklahoma. This development could enhance the company's production capabilities and potentially impact its financial performance.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 10:47 am

AIPI

CRWD

LRNZ

ZS

CrowdStrike Holdings, Inc. (CRWD) has partnered with Dazz to enhance its cloud security offerings and launched a financial services subsidiary to provide financing solutions for its AI-native platform. Additionally, CrowdStrike has integrated AI and Zero Trust capabilities with Zscaler (ZS) to improve security operations. Investors can gain exposure to CrowdStrike through ETFs like TrueShares Technology, AI & Deep Learning ETF (LRNZ) and REX AI Equity Premium Income ETF (AIPI).

Portfolio Pulse from Lekha Gupta

September 18, 2024 | 10:41 am

IMUX

Immunic presented key data at the European Committee for Treatment and Research in Multiple Sclerosis, showcasing the therapeutic potential of its lead asset, Vidofludimus Calcium (IMU-838), in treating multiple sclerosis.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 10:39 am